Lenti-X293T Cells
CAD$759.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | Lenti-X293T cells are a derivative of the human embryonic kidney 293T lineage, engineered and optimized specifically for high-efficiency lentiviral vector production. Like parental 293T cells, they stably express the SV40 large T antigen, which enables episomal replication of plasmids containing the SV40 origin of replication and significantly enhances transient transfection efficiency. Lenti-X293T cells exhibit an adherent epithelial morphology and robust growth characteristics in standard serum-supplemented culture conditions, supporting high-density cultures suitable for large-scale viral production workflows. This cell line has been selected for superior transfection performance using calcium phosphate, lipid-based, or polymer-based reagents, resulting in consistently elevated lentiviral titers compared to conventional HEK293T populations. The enhanced viral output is attributed to optimized cellular physiology that supports efficient plasmid uptake, strong transgene expression, and effective assembly and release of replication-incompetent lentiviral particles when co-transfected with appropriate packaging and envelope constructs. Lenti-X293T cells are therefore widely used for the generation of third-generation lentiviral vectors in gene delivery, gene editing, and stable cell line engineering applications. Lenti-X293T cells maintain the general utility of HEK293-derived systems for high-level recombinant protein expression and transient gene expression studies. Their stable growth characteristics and reproducible performance make them suitable for both small-scale research applications and scalable production settings, provided that standard biosafety and vector packaging guidelines are followed for lentiviral systems. |
|---|---|
| Organism | Human |
| Tissue | Embryonic kidney |
| Disease | Transformed cell line (adenovirus type 5 DNA-transformed HEK cells) |
| Applications | Lentiviral vector production; transient transfection; high-level recombinant protein expression; virus packaging |
| Synonyms | Lenti-X 293T; 293T; HEK 293T |
Characteristics
| Age | Fetus |
|---|---|
| Gender | Female |
| Morphology | Epithelial-like |
| Cell type | Embryonic kidney epithelial cells |
| Growth properties | Adherent; high transfectability; strong viral protein expression |
Regulatory Data
| Citation | Lenti-X293T (Cytion catalog number 305820) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0063 (parental 293T) |
| GMO Status | GMO Status Genetically modified (adenovirus type 5 DNA transformation; SV40 large T antigen expression) |
Biomolecular Data
| Protein expression | SV40 large T antigen |
|---|---|
| Antigen expression | SV40 large T antigen |
| Oncogenes | SV40 large T antigen |
| Tumorigenic | tumorigenic in immunocompromised mice (for 293T) |
| Viruses | Contains adenovirus type 5 DNA; expresses SV40 large T antigen |
| Virus susceptibility | Highly permissive for lentiviral production |
| Ploidy status | Aneuploid, hypotriploid (reported for 293T) |
| Mutational profile | Not fully characterized; contains integrated adenovirus 5 DNA and SV40 large T antigen construct |
| Karyotype | Aneuploid human karyotype with multiple chromosomal abnormalities (typical for 293T) |
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Doubling time | 20-24 hours |
| Subculturing | Split before reaching full confluence; allow up to 48 h for full attachment after thawing |
| Split ratio | A ratio of 1:5 to 1:10 is recommended. |
| Seeding density | 2 to 4 x 104 cells/cm2 |
| Fluid renewal | Every 2-3 days |
| Freeze medium | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305820-220126 | Certificate of Analysis | 02. Mar. 2026 | 305820 |